Endocyte, Inc. (ECYT) Reports In-Line Q4 Loss of 2c/Share

February 25, 2013 4:10 PM EST Send to a Friend
Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.02) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login